Latest filing published 25 Jan 2021 for Zynerba Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Suzanne M. Hanlon: trading record in brief
All filings by Suzanne M. Hanlon on record concern Zynerba Pharmaceuticals, Inc. The record holds 4 filings, for trades running from 5 August 2015 to 21 January 2021.
On the open market, the record shows 2 purchases worth €67k and 1 sale worth €28k. Purchases outweigh sales by €39k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant.
The record was last updated on 25 January 2021 with a share grant in Zynerba Pharmaceuticals, Inc. The last insider purchase was made public on 7 August 2018, 3,016 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Suzanne M. Hanlon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,000 shares0Common StockSEC:0001192482-21-000110:0
- 3,800 shares@ US$5.80100.0% of flowCommon StockSEC:0001192482-18-000385:0Canonical exit: 4 Nov 2018 (T+90)
- 3,000 shares@ US$17.92Common StockSEC:0001123292-16-002600:0Canonical exit: 3 Nov 2015 (T+90)
- 3,000 shares@ US$10.5359.5% of flowCommon StockSEC:0001123292-16-002600:1
4 of 4 declarations
